Macquarie Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $658K | Hold |
899,999
| – | – | ﹤0.01% | 1433 |
|
2025
Q1 | $726K | Hold |
899,999
| – | – | ﹤0.01% | 1428 |
|
2024
Q4 | $1.24M | Hold |
899,999
| – | – | ﹤0.01% | 1311 |
|
2024
Q3 | $936K | Hold |
899,999
| – | – | ﹤0.01% | 1392 |
|
2024
Q2 | $1.56M | Hold |
899,999
| – | – | ﹤0.01% | 1288 |
|
2024
Q1 | $2.15M | Buy |
899,999
+250,000
| +38% | +$598K | ﹤0.01% | 1199 |
|
2023
Q4 | $2.17M | Buy |
649,999
+151,400
| +30% | +$504K | ﹤0.01% | 1199 |
|
2023
Q3 | $1.87M | Buy |
498,599
+68,599
| +16% | +$257K | ﹤0.01% | 1177 |
|
2023
Q2 | $1.84M | Hold |
430,000
| – | – | ﹤0.01% | 1205 |
|
2023
Q1 | $2.94M | Hold |
430,000
| – | – | ﹤0.01% | 1045 |
|
2022
Q4 | $3.41M | Sell |
430,000
-591
| -0.1% | -$4.68K | ﹤0.01% | 1054 |
|
2022
Q3 | $4.15M | Sell |
430,591
-784
| -0.2% | -$7.55K | 0.01% | 1038 |
|
2022
Q2 | $3.12M | Hold |
431,375
| – | – | ﹤0.01% | 1150 |
|
2022
Q1 | $5.57K | Hold |
431,375
| – | – | ﹤0.01% | 1088 |
|
2021
Q4 | $6.89M | Hold |
431,375
| – | – | 0.01% | 1043 |
|
2021
Q3 | $6.93M | Hold |
431,375
| – | – | 0.01% | 1014 |
|
2021
Q2 | $5.97M | Hold |
431,375
| – | – | ﹤0.01% | 1081 |
|
2021
Q1 | $6.3M | Sell |
431,375
-371
| -0.1% | -$5.42K | 0.01% | 852 |
|
2020
Q4 | $7.5M | Hold |
431,746
| – | – | 0.01% | 787 |
|
2020
Q3 | $7.92M | Hold |
431,746
| – | – | 0.01% | 705 |
|
2020
Q2 | $7.71M | Buy |
431,746
+1,746
| +0.4% | +$31.2K | 0.01% | 682 |
|
2020
Q1 | $6.98M | Hold |
430,000
| – | – | 0.01% | 639 |
|
2019
Q4 | $7.74M | Hold |
430,000
| – | – | 0.01% | 698 |
|
2019
Q3 | $8.71M | Hold |
430,000
| – | – | 0.01% | 632 |
|
2019
Q2 | $9.5M | Hold |
430,000
| – | – | 0.02% | 615 |
|
2019
Q1 | $5.87M | Sell |
430,000
-300
| -0.1% | -$4.09K | 0.01% | 734 |
|
2018
Q4 | $3.9M | Hold |
430,300
| – | – | 0.01% | 815 |
|
2018
Q3 | $7.1M | Sell |
430,300
-2,700
| -0.6% | -$44.6K | 0.01% | 710 |
|
2018
Q2 | $6.06M | Buy |
433,000
+13,000
| +3% | +$182K | 0.01% | 736 |
|
2018
Q1 | $4.64M | Buy |
420,000
+23,700
| +6% | +$262K | 0.01% | 776 |
|
2017
Q4 | $3.49M | Buy |
396,300
+106,300
| +37% | +$935K | 0.01% | 871 |
|
2017
Q3 | $3.87M | Sell |
290,000
-20,923
| -7% | -$279K | 0.01% | 819 |
|
2017
Q2 | $4.46M | Buy |
310,923
+263,168
| +551% | +$3.78M | 0.01% | 775 |
|
2017
Q1 | $1.01M | Buy |
47,755
+5,200
| +12% | +$110K | ﹤0.01% | 1177 |
|
2016
Q4 | $1.2M | Sell |
42,555
-15,700
| -27% | -$442K | ﹤0.01% | 1115 |
|
2016
Q3 | $1.56M | Sell |
58,255
-52,855
| -48% | -$1.42M | ﹤0.01% | 1031 |
|
2016
Q2 | $1.88M | Buy |
+111,110
| New | +$1.88M | ﹤0.01% | 1158 |
|